- Liver Abscess in Advanced Hepatocellular Carcinoma after Sorafenib Treatment
-
Shin SK, Jung YK, Yoon HH, Kwon OS, Kim YS, Choi DJ, Kim JH
- KMID: 1711306
- Korean J Gastroenterol.
- 2014 Jan;63(1):47-50.
- doi: 10.4166/kjg.2014.63.1.47
Hepatocellular carcinoma (HCC) is a critical global health issue and the third most common cause of cancer-related deaths worldwide. The majority of patients who present HCC are already at an... -
- CITED
-
- Close
- SHARE
-
- Close
- A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
-
Yang H, Woo HY, Lee SK, Han JW, Jang B, Nam HC, Lee HL, Lee SW, Song DS, Song MJ, Oh JS, Chun HJ, Jang JW, Lozada A, Bae SH, Choi JY, Yoon SK
- KMID: 2413116
- Clin Mol Hepatol.
- 2017 Jun;23(2):128-137.
- doi: 10.3350/cmh.2016.0071
BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS)... -
- CITED
-
- Close
- SHARE
-
- Close
- Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
-
Jeong SW, Jang JY, Shim KY, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Kim KH, Kim JH
- KMID: 1712330
- Gut Liver.
- 2013 Nov;7(6):696-703.
BACKGROUND/AIMS: We investigated the effects of sorafenib monotherapy on advanced hepatocellular carcinoma (HCC) and portal vein tumor thrombosis (PVTT) in a clinical setting. METHODS: In total, 143 consecutive patients with unresectable... -
- CITED
-
- Close
- SHARE
-
- Close
